FiercePharma@FiercePharma15hThe Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K The Oral GLP-1 Tracker: Novo's Wegovy pill back on track as Lilly's momentum slowsFrom fiercepharma.com2282.7K
FiercePharma@FiercePharmaAug 27An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years. As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the groundFrom fiercepharma.com13103.5K
FiercePharma@FiercePharmaAug 25Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancer Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancerFrom fiercepharma.com18193.9K
FiercePharma@FiercePharmaAug 18CSL projections fueled a 17% increase in share price as the Australian plasma and vaccine specialist predicts growth in the immunoglobulin market. CSL shares up 17% as immunoglobulin boost points to signs of recoveryFrom fiercepharma.com12103.4K
FiercePharma@FiercePharmaAug 18EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu EyePoint shares plummet after phase 3 stumble for AMD drug-device combo DuravyuFrom fiercepharma.com263.6K
